Platform combines proprietary AI sequence optimization, novel genetic parts, and lab validation in application-relevant cell models to improve expression and half-life, delivering top candidates in ...

Proteogenomics explores how genetic information translates into protein expression and function, and the role of changes across DNA, RNA, and proteins in influencing disease development and ...

In the rapidly evolving realm of genetics, the integration of artificial intelligence (AI) has ushered in new perspectives on therapeutic approaches and evolutionary processes. Traditional genetic ...

This past year, researchers at Children's Hospital of Eastern Ontario announced the development of a new artificial intelligence-enabled search algorithm that can help identify patients who might have ...

A new artificial intelligence system called DeepRare has beaten experienced rare-disease physicians at their own specialty, ...

The AI in precision medicine market shows strong growth prospects driven by the need for personalized therapies amid rising chronic diseases. Key opportunities include advancements in AI for ...

Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. This voice experience is generated by AI. Learn more. This voice ...

The genetic testing company 23andMe, which holds the genetic data of 15 million people, declared bankruptcy on Sunday night after years of financial struggles. This means that all of the extremely ...

AI in genomics offers transformative opportunities by enhancing drug discovery and personalized medicine through efficient genomic data analysis. Drivers include the surge in genomic data, the focus ...